Roberta Diaz Brinton, PhD

Dr. Roberta Diaz Brinton is one of the nine 2020 WAM Research Grants Recipients and a pioneer in our understanding of the connection between estrogen as a risk factor for developing Alzheimer’s in women. This is the fourth study of hers that WAM is funding, and it focuses on the correlation between Type 2 diabetes therapies as a risk factor for Alzheimer’s and the clinical care provided to diabetic women to protect their long-term health. Her prior research has led to major breakthroughs in understanding more about Alzheimer’s and other therapeutics that might be employed to prevent, delay and potentially treat the disease. Dr. Brinton is among the most prominent researchers working on Alzheimer’s today, and her early research is responsible for forming much of the basis of research critical to personalized therapeutic care for the disease. 


More about Dr. Roberta Diaz Brinton

Dr. Roberta Diaz Brinton leads the Center for Innovation in Brain Science at the University of Arizona and is an internationally recognized expert on women and their risk of Alzheimer’s disease.  Her scientific discoveries have led to the development of innovative therapeutics to prevent, delay and treat Alzheimer’s disease. Brinton is developing the first regenerative therapeutic to regenerate the degenerated brain. Brinton earned her Ph.D. as an NIH Predoctoral Fellow at the University of Arizona and went on to Rockefeller University as an NIH Postdoctoral Fellow. She joined the University of Southern California where she was a Professor of Pharmacology, Biomedical Engineering and Neurology. Brinton returned to her alma mater where she is a Regents Professor of Pharmacology, Neuroscience and Neurology at the University of Arizona College of Medicine – Tucson.  

Brinton serves on the Women Alzheimer’s Movement Scientific Advisory Council, the National Institutes of Health Director’s Advisory Committee, the National Institute on Aging Board of Scientific Counselors and the Alzheimer’s Drug Discovery Foundation (ADDF) Board of Governors. Her honors include the ADDF Scientist of the Year, the Melvin R. Goodes Prize for Excellence in Alzheimer’s Drug Discovery and the 2010 U.S. Presidential Citizens Medal, the highest civilian honor for her work in improving science and technology education for students.

If you would like to learn more about Dr. Roberta Diaz Brinton’s clinical trial click HERE